Skip to main content

Table 3 Baseline demographic and clinical characteristics of subjects in the study group

From: Feasibility and preliminary efficacy of different intensities of functional training in elderly type 2 diabetes patients with cognitive impairment: a pilot randomised controlled trial

Variable

HIFT

LIFT

Control

P value

Age

66.47 ± 6.61

68.35 ± 5.44

67.76 ± 5.49

0.784

Height

164.33 ± 5.42

167.77 ± 6.38

165.21 ± 6.16

0.413

Weight

76.13 ± 7.76

74.35 ± 4.19

78.67 ± 5.54

0.388

BMI

28.25 ± 1.85

26.36 ± 2.31

28.86 ± 2.04

0.442

FBG (mg/dl)

208.75 ± 38.42

214.33 ± 35.24

205.58 ± 40.11

0.559

Insulin (mu/l)

10.10 ± 1.69

10.82 ± 1.46

9.96 ± 1.74

0.885

HOMA-IR

5.21 ± 1.33

5.73 ± 1.41

4.97 ± 1.38

0.611

HbA1c %

8.88 ± 1.91

9.07 ± 2.03

8.85 ± 1.85

0.731

SBP

146.14 ± 15.88

141.76 ± 16.13

142.24 ± 11.33

0.506

DBP

94.65 ± 5.33

92.54 ± 6.11

93.34 ± 6.08

0.572

MMSE

18.62 ± 2.84

19.08 ± 2.45

18.86 ± 2.57

0.724

  1. HIFT: high-intensity functional training; LIFT: low-intensity functional training; BMI: body mass index; FBG: fasting blood glucose; HOMA-IR: homeostasis model assessment of insulin resistance; HbA1c: hemoglobin A1c; SBP: systolic blood pressure; DBP: diastolic blood pressure; MMSE: Mini–Mental State Examination